Gsk (GLAXF) Other Non-Current Assets (2009 - 2026)

Gsk's Other Non-Current Assets history runs 18 years deep, the most recent figure standing at $3.2 billion for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 24.92% year-over-year to $3.2 billion; the TTM figure through Mar 2026 stood at $3.2 billion (up 24.92% YoY), while the FY2025 annual figure was $2.8 billion, up 14.09% from the prior year.
• Other Non-Current Assets was $3.2 billion for Q1 2026 at Gsk, up from $2.9 billion in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $3.2 billion in Q1 2026 to a low of $32.2 million in Q1 2022.
• Historically, Other Non-Current Assets has averaged $2.1 billion across 5 years, with a median of $2.2 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets plunged 97.64% in 2022, then surged 5546.5% in 2023.
• A 5-year view of Other Non-Current Assets shows it stood at $1.4 billion in 2022, then jumped by 40.38% to $2.0 billion in 2023, then grew by 26.78% to $2.5 billion in 2024, then advanced by 14.63% to $2.9 billion in 2025, then rose by 11.4% to $3.2 billion in 2026.
• The last three Other Non-Current Assets figures came in at $3.2 billion (Q1 2026), $2.9 billion (Q4 2025), and $2.9 billion (Q3 2025), per Business Quant data.